Alembic Pharmaceuticals Ltd. announced its consolidated third quarter results ended March 31, 2025, which recorded good performance in core business operations. The company’s net sales grew 17% ...

Alembic Pharma (ALPM) delivered a better-than-expected performance in 4QFY25. A strong performance in export markets was offset partly by a muted show in domestic formulation (DF) segment. API ...

- Per. of shares (as a % of the total sh. of prom. and promoter group)----- - Per. of shares (as a % of the total Share Cap. of the company)----- Advisory Alert: It has come to our attention ...

HUNTINGTON — The folks at Huntington’s Alchemy Theatre Troupe are hosting a free audition workshop at 7 p.m. Wednesday, May 14, at the Geneva Kent Center for the Arts located, 68 Holley Road ...

Melissa Fleur Afshar is a Newsweek reporter based in London, United Kingdom. Her current focus is on trending life stories and human-interest features on a variety of topics ranging from ...

GameSpot may get a commission from retail offers. Oblivion Remastered is here! The Elder Scrolls IV: Oblivion is a favorite in Bethesda's long-running series for many players, which makes Oblivion ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Vadodara-based Alembic Pharmaceuticals posted a 12 per cent year-on-year drop in net profit for the fourth quarter of the 2024–25 financial year to Rs 157 crore as its net sales increased by 17 per ...

Alembic Pharmaceuticals reported a mixed set of numbers for the March quarter, with a drop in profitability despite healthy top-line growth. The company’s consolidated net profit fell 11.8% ...